Remdesivir

Remdesivir scam: BMC cleared, govt urges to legislate against drugs' misuse

Simultaneously, the Lokayutka, Justice V.M. Kanade, has urged the Maharashtra government to enact suitable legislation to ensure availability of life-saving drugs at reasonable prices

SEBI asks pharma companies to disclose details that can impact stock prices

The details that need to be disclosed are new drugs, pending patents, source of raw materials, and new partnerships, among others

Centre suspends 3 scientists over fake Remdesivir sale in Covid 2nd wave

The development comes at a time when the Central Drugs Standard Control Organisation has been accused of a bribery scandal allegedly involving a senior Biocon executive

US FDA approves first Covid-19 treatment Veklury for young children

Veklury is approved for young children who are hospitalised, or have mild-to-moderate Covid-19 and are at high risk for progression to severe Covid-19, according to the FDA

Govt removes export curbs on Remdesivir, active pharmaceutical ingredients

The Centre has also removed similar curbs for exports of organic LEDs (Light Emitting Diodes) and liquid crystals

Remdesivir to be used in patients with moderate to severe Covid-19: Govt

The Centre on Friday said Remdesivir drug should only be used in patients with moderate to severe' COVID-19 and those with no renal or hepatic dysfunction within 10 days of the onset of any symptom. It also warned against use of the drug in patients who are not on oxygen support or in home settings. According to the clinical guidance issued by the Union health ministry for management of the infection in adult patients, Remdesivir has been asked to be used in patients with moderate to severe COVID-19 and those with no renal or hepatic dysfunction within 10 days of onset of any symptom. The Tocilizumab drug may be considered for use in the presence of severe disease (preferably within 24 to 48 hours of onset of severe disease/ICU admission), according to the guidelines. Tocilizumab can be used in case of significantly raised inflammatory markers (CRP &/or IL-6), condition not improving despite use of steroids and no active bacterial/fungal/tubercular infection. The ministry also ...

Production capacity of Remdesivir ramped up by more than 3-times

India now has capacity to manufacture 12.25 mn vials a month

Remdesivir, HCQ show no antiviral effect against Covid, says study

Remdesivir and hydroxychloroquine (HCQ) showed no antiviral activity in hospitalised patients with Covid-19 in Norway, according to a study published on Tuesday.

Govt issues guidelines for Covid in children, discourages use of Remdesivir

The Director General of Health Services (DGHC) under the Union Health Ministry on Wednesday issued guidelines for the management of Covid-19 in children below 18 years of age

Govt stops central allocation of Remdesivir to states as supply improves

The Centre has stopped allocation of antiviral drug Remdesivir to states as the supply of the critical medication has surpassed the demand, Union Minister Mansukh L Mandaviya said on Saturday. "Now the country has enough #Remdesivir as the supply is much more than the demand. So we have decided to DISCONTINUE the Central Allocation of Remdesivir to States," Mandaviya said in a tweet. The Minister of State for Chemicals and Fertilisers noted that the supply of the drug, which is being used to treat COVID-19, has been ramped up over ten times from just 33,000 vials a day on April 11, 2021 to 3,50,000 vials per day currently. The government has also increased the number of plants producing Remdesivir from just 20 to 60 plants within a month, he added. Besides, the Centre has decided to procure 50 lakh vials of Remdesivir to maintain it as a strategic stock for emergency requirement, Mandaviya said. "But I have also directed @nppa_india & @CDSCO_INDIA_INF to continuously monitor the .

Remdesivir production ramped up 10 times, says Mansukh Mandaviya

Taking to Twitter he said that the number of plants producing Remdesivir have also increased from just 20 to 60 within a month.

India records 240,000 fresh Covid-19 cases, 3,741 fatalities

The daily rise in coronavirus cases in India remained below the 300,000mark for the seventh consecutive day, with 240,000 cases recorded in a single day, the Union Health Ministry said on Sunday

People selling Remdesivir illegally booked under NSA: Adityanath

Uttar Pradesh Chief Minister Yogi Adityanath on Saturday said those indulging in black-marketing of Remdesivir injections in the state are being booked under the stringent National Security Act (NSA).

Amid concerns over effectiveness, govt ramping up Remdesivir production

Remdesivir may soon be dropped from ICMR's Covid treatment protocol, as experts have questioned its effectiveness in Covid treatment.

Remdesivir may be dropped soon for treatment of Covid patients: Dr Rana

"All the experimental medicines, be plasma therapy (which is now discontinued) or Remdesivir, all of them may be dropped soon as there is no such evidence of its functioning," said Dr Rana

Covid-19: Remdesivir production scaled up to 11.9 million vials per month

All seven domestic licensed manufacturers of Remdesivir have scaled up production from 3.8 million vials per month to nearly 11.9 million vials per month, following government directives

Remdesivir coordination lacking between Centre, state: Gujarat HC

The Gujarat High Court said there appears to be 'lack of coordination' between the Centre and the state government in the allocation of the required amount of Remdesivir injections

India got 530,000 Remdesivir, 13,496 oxygen cylinders as foreign aid: Govt

Health ministry said 11,058 oxygen concentrators, 13,496 oxygen cylinders, 19 oxygen generation plants and about 530,000 Remdesivir received as global aid have been delivered to various states/UTs

Coronavirus: Remdesivir allocated till May 23 to States/UTs, says Gowda

The Ministry of Chemicals and Fertilizers has made adequate allocation of Remdesivir injection till May 23 for the treatment of Covid patients, it said.

Anti-viral Remdesivir will be given directly to hospitals, says TN Govt

Remdesivir would be made available directly to private hospitals to avoid overcrowding in places designated for its prescription-based sale by state authorities to the kin of Covid patients